Molina Healthcare grants director Brasier 304 shares

Each director’s annual equity award is set at $220,000; $55,000 is granted on the first day of each quarter based on that day’s closing price.

Rhea-AI Filing Summary

Molina Healthcare, Inc. director Barbara L. Brasier received a 304-share common-stock grant on October 1, 2026, under the 2025 Equity Incentive Plan. The grant was based on the stock’s $180.85 closing price that day. Her direct holdings after the transaction were 6,122 shares.

Insider Trade Summary

Grant/Award: 304 shares

Grant/Award 1 txn

Insider BRASIER BARBARA L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2, F3	304	$180.85	$55K

Holdings After Transaction: Common Stock — 6,122 shares (Direct)

Footnotes (3)

1. F1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
2. F2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.
3. F3. Represents the closing price of the Issuer's common stock on October 1, 2026.

Key Figures

Shares granted: 304 shares Closing price: $180.85 per share Direct holdings after transaction: 6,122 shares +2 more

5 metrics

Shares granted 304 shares Common stock grant on October 1, 2026

Closing price $180.85 per share October 1, 2026

Direct holdings after transaction 6,122 shares Barbara L. Brasier

Annual equity award $220,000 Award amount set for each director

Quarterly equity award $55,000 Granted on the first day of each quarter

Key Terms

2025 Equity Incentive Plan, annual equity award, closing price

3 terms

2025 Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan"

annual equity award financial

"The aggregate dollar value of the annual equity award to each director"

closing price financial

"based on the closing price of the Issuer's common stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MOH shares did director Barbara L. Brasier receive?

Barbara L. Brasier received a grant of 304 shares of Molina Healthcare common stock on October 1, 2026, based on a closing price of $180.85 per share; her direct holdings after the transaction were 6,122 shares.

What is the MOH director equity award amount?

Molina Healthcare set the annual equity award for each director at $220,000, with one quarter, or $55,000, granted on the first day of each quarter based on the common stock’s closing price on that day.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/02/2026 - 04:45 PM Accepted by SEC EDGAR 10/02/2026 - 04:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BRASIER BARBARA L

(Last) (First) (Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2026		A(1)		304(2)	A	$180.85(3)	6,122	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.

3. Represents the closing price of the Issuer's common stock on October 1, 2026.

Remarks:

	Jeff D. Barlow, by power of attorney for Barbara L. Brasier	10/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)